DOAC Therapy
With guidelines recommending the use of DOACs for stroke prevention in atrial fibrillation (AF), we have seen an increasing number of patients using these therapies. There are common errors that are made in terms of dosing, monitoring and managing patients on these therapy. Thrombosis Canada has some incredible tools on appropriate use of DOACs and clinical tools for practice. A couple of great tools include the following:
- NOACs/DOACs*: Comparison And Frequently Asked Questions
- Direct Oral Anticoagulation (DOAC) Monitoring Checklist for Pharmacists
- NOACs/DOACs*: Perioperative Management
If you haven’t reviewed the Thrombosis Canada website, I would encourage you to do so.
DOACs Interactive Quiz (15 T/F Questions)
I thought I would do a quiz on some of the key therapeutic issues with DOACs. I hope you like it.
References
- NOACs/DOACs*: Comparison And Frequently Asked Questions
- Direct Oral Anticoagulation (DOAC) Monitoring Checklist for Pharmacists
- NOACs/DOACs*: Perioperative Management